You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / AUROBINDO PHARMA

AUROBINDO PHARMA
Intrinsic Value | Fundamental Analysis

Returns | 1W : -5.8% , 1M : -6.2%,1Y : 17.5%
BOM : 524804     NSE : AUROPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jul 29,2021
Price(EOD): Rs. 908.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
AUROBINDO PHARMA -5.8% -6.2% 17.5%
SUN PHARMACEUTICAL INDUSTRIES 1.3% 3.8% 44.6%
DR REDDYS LABORATORIES -13.9% -14% 17.8%
DIVIS LABORATORIES 0.5% 11.2% 107.1%
CIPLA -6.9% -9.9% 36.4%
BIOCON -4% -6.2% -4.5%
LUPIN -8.1% -6.5% 30.6%
TORRENT PHARMACEUTICALS -0.2% 4% 34.1%
CADILA HEALTHCARE -7% -10.7% 62.2%


FUNDAMENTAL ANALYSIS OF AUROBINDO PHARMA

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than AUROBINDO PHARMA Plus/Pro


VALUATION OF AUROBINDO PHARMA

 
Valuation Score
[As on : Jul 29,2021 ]

Ratio Consolidated
P/E
P/B
P/S
18.8
P/E Calculated based on EPS of 48.32
[ Mar2020 - Consolidated Results ]

3.17
P/B Calculated based on Book Value of 286.92
[ Mar2020 - Consolidated Results ]

2.15
P/S Calculated based on Revenues of 24774.6 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than AUROBINDO PHARMA Plus/Pro


FAIR VALUE OF AUROBINDO PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
16%
-56%
-47%

SHARE PRICE MOMENTUM OF AUROBINDO PHARMA

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.29
0.4
0.37
0.35
0.33
0.5
0.41
0.41
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
20.66 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-5.71%
-6.86%
-73.4%
-72.66%
-2.55%
-3.16%
-2.51%
-8.26%
QtrlyTrend
-8
Latest Qtr: Mar2021

AUROBINDO PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP -0.2% 1.3% 52.6%
S&P BSE 500 -0.3% 1.2% 50.9%
S&P BSE 200 -0.4% 0.6% 47.2%
S&P BSE 250 LARGEMIDCAP -0.4% 0.7% 47.8%
S&P BSE LARGE MIDCAP -0.4% 0.5% 45.7%
S&P BSE 100 LARGECAP TMC -0.4% 0.2% 42.9%
S&P BSE LARGECAP -0.4% 0.3% 42.5%
S&P BSE 100 -0.5% 0.5% 43.7%
S&P BSE SENSEX NEXT 50 -0.5% 1.1% 58%
S&P BSE CARBONEX -0.5% 0.2% 43.7%
S&P BSE DIVIDEND STABILITY -1% -2.5% 44.9%
S&P BSE MOMENTUM -1.2% -0.5% 34.2%
S&P BSE QUALITY -1.4% 1% 48.9%
S&P BSE HEALTHCARE -2.8% 0.1% 52.1%
NSE Indices1W1M1Y
NIFTY 100 EQUAL WEIGHT -0.3% 1% 56.3%
NIFTY NEXT 50 -0.3% 1.3% 49.9%
NIFTY 500 -0.3% 1.2% 50.5%
NIFTY 200 -0.4% 0.6% 46.2%
NIFTY 100 -0.5% 0.3% 42.3%
NIFTY500 MULTICAP 50:25:25 -0.6% 1.9% NA
NSE QUALITY 30 -0.6% 0.2% 38.9%
NIFTY LARGE MIDCAP 250 -0.7% 0.5% 58.4%
NIFTY GROWTH SECTOR 15 -1.9% -1.5% 38%
NIFTY HEALTHCARE -3.1% -0.1% NA
NIFTY PHARMA -4.6% -2.9% 38.8%

FAQ [Frequently Asked Questions]


Is AUROBINDO PHARMA good for long term investment?

As on 29-Jul-2021, the Fundamentals of AUROBINDO PHARMA look Strong and hence it may be good for long term investment! See Financial Performance of AUROBINDO PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AUROBINDO PHARMA UnderValued or OverValued?

As on 29-Jul-2021, AUROBINDO PHARMA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AUROBINDO PHARMA ?

As on 29-Jul-2021, the Intrinsic Value of AUROBINDO PHARMA is Rs. 1,712.89 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 780.75
Fair Value [Median EV / Sales Model] : Rs. 2,065.37
Fair Value [Median Price / Sales Model] : Rs. 1,712.89
Median Fair Value of AUROBINDO PHARMA : Rs. 1,712.89

Is AUROBINDO PHARMA trading at a Premium or Discount?

As on 29-Jul-2021, AUROBINDO PHARMA is trading at a Discount of -47% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of AUROBINDO PHARMA ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of LUPIN LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD
Quarterly Results of ALKEM LABORATORIES LTD

What are the Frequent Comparisons with AUROBINDO PHARMA ?

Compare Analytics
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
AUROBINDO PHARMA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ALKEM LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of LUPIN LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of ALKEM LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z